Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex. . Cephalalgia 2024;44:3331024241254952.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex. Cephalalgia 2024;44:3331024241254952.
PMID: 38907336